Document Detail

Evaluation of osteoporosis risk assessment in veterans receiving androgen-deprivation therapy.
MedLine Citation:
PMID:  21224198     Owner:  NLM     Status:  In-Data-Review    
Objective: To identify whether veterans receiving androgen-deprivation therapy (ADT) are screened at any time by bone mass measurement.Design: Cross-sectional study.Setting: Veterans Administration Tennessee Valley Healthcare System (VA-TVHS).Patients: All male veterans who received at least one dose of goserelin or leuprolide within the fiscal years October 1, 2005, through September 30, 2009.Interventions: Data from patients' charts were extracted for demographic information (race, age, and weight prior to the initial injection); date of initiation of therapy; the use of calcium, vitamin D, bisphosphonate, or calcitonin therapy; and documented bone-mineral density testing.Main Outcome Measure: To determine whether veterans receiving ADT with goserelin or leuprolide for prostate cancer were screened at any time for BMD more or less than rates as documented in previous literature.Results: 22.8% of veterans were screened for BMD, which was statistically significant when compared with results found in previous literature.Conclusion: Although rates of BMD testing were higher at VA-TVHS compared with previous literature, this rate is still low given the well-known risk of accelerated osteoporosis associated with ADT.
Valerie D'Alesio; Brent E Salvig; T Neal Fourakre
Related Documents :
19592388 - Randomised trial of three rapamycin-eluting stents with different coating strategies fo...
19659998 - Triple antiplatelet therapy vs. dual antiplatelet therapy in patients undergoing percut...
23331468 - Association between self reported snoring, stop questionnaire and postoperative pulmona...
22032518 - Functional results of temporalis fascia versus cartilage tympanoplasty in patients with...
19507638 - Vascularized free fibular graft in the treatment of congenital pseudarthrosis of tibia.
20865098 - Greatest international antiinfective trial (giant) with moxifloxacin in the treatment o...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists     Volume:  26     ISSN:  0888-5109     ISO Abbreviation:  Consult Pharm     Publication Date:  2011 Jan 
Date Detail:
Created Date:  2011-01-12     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9013983     Medline TA:  Consult Pharm     Country:  United States    
Other Details:
Languages:  eng     Pagination:  43-7     Citation Subset:  IM    
Veterans Administration Tennessee Valley Healthcare System, Nashville, Tennessee.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Methadone: marvelous, malevolent, or merely misunderstood?
Next Document:  Selegiline and rasagiline: twins or distant cousins? Guidelines.